Effectiveness of ciclesonide nasal spray in the treatment of seasonal allergic rhinitis

Annals of Allergy, Asthma and Immunology

Volumn 97, Issue 5, 2006, Pages 657-663

  Ratner, Paul H ^a,g   Wingertzahn, Mark A ^b   Van Bavel, Julius H ^c   Hampel, Frank ^d   Darken, Patrick F ^a   Hellbardt, Stefan ^e   Brookman, Sheldon ^f   Shah, Tushar ^a  

^a Sylvana Research   (United States)

^b ALTANA Pharma US Inc   (United States)

^c Allergy and Asthma Associates   (United States)

^d Central Texas Health Research   (United States)

^e ALTANA PHARMA AG   (Germany)

^f TEIJIN America Inc   (United States)

^g Sylvana Research Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPHENIRAMINE MALEATE; CICLESONIDE; CORTICOSTEROID; DESISOBUTYRYLCICLESONIDE; NOSE SPRAY; PLACEBO; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE DURATION; DIZZINESS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG SELF ADMINISTRATION; DRUG TOLERABILITY; DRUG WITHDRAWAL; EPISTAXIS; FEMALE; HAY FEVER; HEADACHE; HUMAN; INCIDENCE; INTRAOCULAR PRESSURE ABNORMALITY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NASAL PRURITUS; NOSE CONGESTION; NOSE IRRITATION; PARALLEL DESIGN; PHARYNGITIS; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINORRHEA; SCORING SYSTEM; SNEEZING; SYMPTOM; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; URTICARIA;

EID: 33845206318     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)61097-6     Document Type: Article

References (27)

1. Skoner DP. Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis. J Allergy Clin Immunol. 2001;108(suppl):S2-S8.
2. Berger WE. Overview of allergic rhinitis. Ann Allergy Asthma Immunol. 2003;90(suppl 3):7-12.
3. Bousquet J, Jacquot W, Vignola AM, et al. Allergic rhinitis: a disease remodeling the upper airways? J Allergy Clin Immunol. 2004;113:43-49.
4. Gelfand EW. Inflammatory mediators in allergic rhinitis. J Allergy Clin Immunol. 2004;114:8135-8138.
5. Thompson AK, Juniper E, Meltzer EO. Quality of life in patients with allergic rhinitis. Ann Allergy Asthma Immunol. 2000;85:338-347.
6. Bloebaum R. Managing allergic rhinitis: the role of pharmacotherapy; sound treatment can improve your patient's quality of life. J Respir Dis. 2002;23:370-376.
7. Storms WW. Pharmacologic approaches to daytime and nighttime symptoms of allergic rhinitis. J Allergy Clin Immunol. 2004;114:S146-S153.
8. Nielsen LP, Dahl R. Comparison of intranasal corticosteroids and antihistamines in allergic rhinitis: a review of randomized, controlled trials. Am J Respir Med. 2003;2:55-65.
9. Stoeck M, Riedel R, Hochhaus G, et al. In vitro and in vivo anti-inflammatory activity of the new glucocorticoid ciclesonide. J Pharmacol Exp Ther. 2004;309:249-258.
10. Mealy NE, Bayés M, Castañer J. Ciclesonide: treatment of allergic rhinitis antiallergy/antiasthmatic. Drugs Future. 2001;26:1033-1039.
11. Schmidt B, Timmer W, Georgens AC, et al. The new topical steroid ciclesonide is effective in the treatment of allergic rhinitis. J Clin Pharmacol. 1999;39:1062-1069.
12. Dietzel K, Engelstätter R, Keller A. Ciclesonide: an on-site-activated steroid. In: Hansel TT, Barnes PJ, eds. New Drugs for Asthma, Allergy and COPD. Progress in Respiratory Research, vol 31. Basel, Switzerland: Karger; 2001:91-93.
13. Wingertzahn M, Sato H, Nave R, et al. Uptake and activation of ciclesonide (CIC) in hypotonic and isotonic suspensions and the formation of fatty acid conjugates of desisobutyryl-ciclesonide (des-CIC) in vivo in rabbit nasal mucosa. Paper presented at: 23rd Annual Aspen Allergy Conference; July 26-30, 2005; Aspen, Colorado.
14. Nave R, Meyer W, Fuhst R, et al. Formation of fatty acid conjugates of ciclesonide active metabolite in the rat lung after 4-week inhalation of ciclesonide. Pulm Pharmacol Ther. 2005;18:390-396.
15. Wingertzahn MA, Sato H, Nave R, et al. Comparison of nasal tissue concentrations in rabbits following administration of hypotonic and isotonic ciclesonide suspensions [abstract]. J Allergy Clin Immunol. 2005;115(suppl): S126. Abstract 503.
16. Allen DB, Bielory L, Derendorf H, et al. Inhaled corticosteroids: past lessons and future issues. Allergy Clin Immunol. 2003;112:S1-S40.
17. Nave R, Hummel R-P, Wohlsen A, et al. The active metabolite of ciclesonide, des-isobutyryl ciclesonide, forms highly lipophilic fatty acid conjugates in precision-cut rat lung slices [abstract]. Am J Respir Crit Care Med. 2004;169(suppl):A91.
18. Bernstein IL. Is the use of benzalkonium chloride as a preservative for nasal formulations a safety concern? a cautionary note based on compromised mucociliary transport. J Allergy Clin Immunol. 2000;105:39-44.
19. Bachert C, El-Akkad T. Patient preferences and sensory comparisons of three intranasal corticosteroids for the treatment of allergic rhinitis. Ann Allergy Asthma Immunol. 2002;89:292-297.
20. van Adelsberg J, Philip G, Pedinoff AJ, et al. Montelukast improves symptoms of seasonal allergic rhinitis over a 4-week treatment period. Allergy. 2003;58:1268-1276.
21. Salmun LM, Lorber R. 24-hour efficacy of once-daily desloratadine therapy in patients with seasonal allergic rhinitis. BMC Fam Pract. 2002;3:14.
22. Nasonex (mometasone furoate monohydrate) [product information]. Kenilworth, NJ: Schering Corp; 2003.
23. Dykewicz MS, Kaiser HB, Nathan RA, et al. Fluticasone propionate aqueous nasal spray improves nasal symptoms of seasonal allergic rhinitis when used as needed (prn). Ann Allergy Asthma Immunol. 2003;91:44-48.
24. Weiler JM, Meltzer EO, Benson PM, et al. A dose-ranging study of the efficacy and safety of azelastine nasal spray in the treatment of seasonal allergic rhinitis with an acute model. J Allergy Clin Immunol. 1994;94:972-980.
25. Weiler JM, Gellhaus M, Donnelly A, et al. Randomized, double-blind, parallel groups, placebo-controlled study of efficacy and safety of Rynatan in the treatment of allergic rhinitis using an acute model. Ann Allergy. 1990;64:63-67.
26. Weiler JM, Meltzer EO. Azelastine nasal spray as adjunctive therapy to azelastine tablets in the management of seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 1997;79:327-332.
27. Meltzer EO, Weiler JM, Dockhorn RJ, et al. Azelastine nasal spray in the management of seasonal allergic rhinitis. Ann Allergy. 1994;72:354-359.